Feb 13, 2024 / 12:00AM GMT
Presentation
Feb 13, 2024 / 12:00AM GMT
=====================
Corporate Participants
=====================
* Andy Schmeltz
CSL Limited - EVP of CSL Behring Business Unit
* Herve Gisserot
Vifor Pharma AG - Chief Commercial Officer
* Joy Carolyn Linton
CSL Limited - CFO
* Mark Dehring
CSL Limited - Head of IR
* Paul F. McKenzie
CSL Limited - MD, CEO & Executive Director
* Stephen Marlow
CSL Limited - Senior VP & GM of Seqirus
* William Mezzanotte
CSL Limited - Executive VP & Head of Research and Development
=====================
Conference Call Participants
=====================
* Andrew Goodsall
MST Financial Services Pty Limited, Research Division - Senior Analyst
* Andrew Paine
CLSA Limited, Research Division - Research Analyst
* Craig Wong-Pan
RBC Capital Markets, Research Division - Director of Equity Research & Equity Research Analyst
* David Bailey
Macquarie Research - Analyst
*
CSL Ltd
(ASX:CSL)
A$
121.95
+0.20 (+0.16%)
Market Cap: 58.31 Bil
Enterprise Value: 75.52 Bil
PE Ratio: 98.82
PB Ratio: 2.09
GF Score: 78/100 Half Year 2024 CSL Ltd Earnings Presentation Transcript
Feb 13, 2024 / 12:00AM GMT
Release Date Price:
A$282.25
(-2.75%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot